Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Siegfried Holding AGSGFEF 84 Median PS Value is $87.54 as of Jul. 16, 2026, which is 6482% above its 10-year median of 1.33. GuruFocus rates SGFEF with a GF Score™ of 84/100 and a GF Value™ of $129.30 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 544 Drug Manufacturers companies, Siegfried Holding AG ranks worse than 57.72% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Siegfried Holding AG's Median PS Value or its related term are showing as below:
SGFEF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.88 Med: 1.33 Max: 1.94
Current: 0.96
During the past 13 years, the highest Price to Median PS Value of Siegfried Holding AG was 1.94. The lowest was 0.88. And the median was 1.33.
SGFEF's Price-to-Median-PS-Value is ranked worse than 57.72% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.9
vs SGFEF: 0.96
Siegfried Holding AG (OTCPK:SGFEF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Siegfried Holding AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
84.12
/
87.54
=
0.96
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siegfried Holding AG Median PS Value Related Terms
Siegfried Holding AG Median PS Value Historical Data
* Premium members only.
The historical data trend for Siegfried Holding AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGFEF vs ZTS, UTHR, VTRS: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siegfried Holding AG Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Siegfried Holding AG's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.3286.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Siegfried Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $37.594.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siegfried Holding AG (SGFEF) has a Median PS Value of $87.54 as of Jul. 16, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Siegfried Holding AG and its competitors. This is 6482% above median its historical median of 1.33. Over the past decade, Siegfried Holding AG's Median PS Value has ranged from 0.88 to 1.94. According to the industry distribution chart, Siegfried Holding AG ranks #314 out of 544 companies in the Drug Manufacturers industry, placing it in the top 57.7%.
Is Siegfried Holding AG's Median PS Value too high?
Siegfried Holding AG's current Median PS Value of $87.54 is 6482% above median its 10-year median of 1.33. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 1.94. The Drug Manufacturers industry median Median PS Value is 0.90. Siegfried Holding AG's value of $87.54 is 9626.7% above this industry median. Based on the distribution chart, Siegfried Holding AG ranks #314 out of 544 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Siegfried Holding AG has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #314 out of 544 companies for Median PS Value. This places Siegfried Holding AG in the lower half of its industry. The industry median Median PS Value is 0.90. Siegfried Holding AG's value of $87.54 is 9626.7% above this benchmark. Historically, Siegfried Holding AG's own Median PS Value has ranged from 0.88 to 1.94 over the past decade. While the company's 10-year median is 1.33 vs. the industry median of 0.90, Siegfried Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.90, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siegfried Holding AG's current Median PS Value of $87.54 is 9626.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Siegfried Holding AG and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current Median PS Value is $87.54, which is 6482% above median its own 10-year median of 1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (SGFEF) is currently considered Significantly Undervalued. The stock's GF Value™ is $129.30, compared to a current price of $84.12 — trading 34.9% below its estimated fair value. The current Median PS Value is $87.54, which is 6482% above median its 10-year median of 1.33 and 9626.7% above the Drug Manufacturers industry median of 0.90. Siegfried Holding AG's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Siegfried Holding AG (SGFEF), the current Median PS Value is $87.54 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siegfried Holding AG (SGFEF) Overvalued in 2026?
Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued.
The current stock price of $84.12 is trading 34.9% below its estimated GF Value™ of $129.30.
GuruFocus considers Siegfried Holding AG to be Significantly Undervalued.
Key valuation signals for SGFEF:
Median PS Value: $87.54 (6482% above median its 10-year median of 1.33)
GF Value™: $129.30 vs. price of $84.12 (34.9% below fair value)
Industry Position: 9626.7% above the Drug Manufacturers median (#314 of 544)
No single metric tells the full story. See the SGFEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
84GF Score
Get the complete analysis for SGFEF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGFEF has been successfully added to your 
